ScoreWhy is Dr Agarwals Eye Hospital Ltd ?
1
Healthy long term growth as Operating profit has grown by an annual rate 83.03%
2
The company has declared Positive results for the last 4 consecutive quarters
- OPERATING PROFIT TO INTEREST(Q) Highest at 16.93 times
- PBT LESS OI(Q) At Rs 20.68 cr has Grown at 76.00%
- PAT(Q) At Rs 17.28 cr has Grown at 66.2%
3
With ROCE of 16.6, it has a Fair valuation with a 4.5 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 7.52%, its profits have risen by 35.8% ; the PEG ratio of the company is 1
4
29.26% of Promoter Shares are Pledged
- In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Dr Agarwal's Eye should be less than 10%
- Overall Portfolio exposure to Hospital should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Hospital)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Dr Agarwal's Eye for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Dr Agarwal's Eye
7.52%
0.19
39.07%
Sensex
7.07%
0.61
11.53%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
28.55%
EBIT Growth (5y)
83.03%
EBIT to Interest (avg)
7.24
Debt to EBITDA (avg)
2.67
Net Debt to Equity (avg)
0.77
Sales to Capital Employed (avg)
0.91
Tax Ratio
23.21%
Dividend Payout Ratio
5.16%
Pledged Shares
29.26%
Institutional Holding
4.18%
ROCE (avg)
15.21%
ROE (avg)
29.83%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
32
Industry P/E
58
Price to Book Value
7.20
EV to EBIT
25.23
EV to EBITDA
17.52
EV to Capital Employed
4.51
EV to Sales
5.57
PEG Ratio
1.01
Dividend Yield
0.14%
ROCE (Latest)
16.58%
ROE (Latest)
22.20%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
OPERATING PROFIT TO INTEREST(Q)
Highest at 16.93 times
PBT LESS OI(Q)
At Rs 20.68 cr has Grown at 76.00%
PAT(Q)
At Rs 17.28 cr has Grown at 66.2%
DEBT-EQUITY RATIO(HY)
Lowest at 1.07 times
NET SALES(Q)
At Rs 116.22 cr has Grown at 22.20%
-3What is not working for the Company
ROCE(HY)
Lowest at 14.81%
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 7.89 cr
Loading Valuation Snapshot...
Here's what is working for Dr Agarwal's Eye
Operating Profit to Interest - Quarterly
Highest at 16.93 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 20.68 cr has Grown at 76.00%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 17.28 cr has Grown at 66.2%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
At Rs 116.22 cr has Grown at 22.20%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Debt-Equity Ratio - Half Yearly
Lowest at 1.07 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Dr Agarwal's Eye
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 7.89 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
